Teresa Gray
Family · Barbourville, KYNPI 1891050779
Payments from drug & device makers
Across 176 payments — averaging $16.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$920
- GSK$184
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
- Otsuka America Pharmaceutical, Inc.$123
- Phathom Pharmaceuticals, Inc.$105
- plus $300 from 10 others
What the payments were for
- Food & beverage$2,94198%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $1,214 |
| AbbVie | 91 | $920 |
| GSK | 11 | $184 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $123 |
| Phathom Pharmaceuticals, Inc. | 12 | $105 |
| Verona Pharma, Inc. | 3 | $65 |
| Pfizer | 3 | $44 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Alkermes, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Resmed Corp | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,990 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 167 | $104,687 |
| OzempicSemaglutide | 70 | $67,197 |
| FarxigaDapagliflozin Propanediol | 80 | $48,775 |
| CaplytaLumateperone Tosylate | 28 | $46,325 |
| LinzessLinaclotide | 51 | $32,438 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 47 | $28,843 |
| UbrelvyUbrogepant | 27 | $27,609 |
| EliquisApixaban | 45 | $24,149 |
| TrulicityDulaglutide | 22 | $20,716 |
| QuliptaAtogepant | 11 | $13,923 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 31 | $13,072 |
| Spiriva RespimatTiotropium Bromide | 17 | $11,925 |
| MounjaroTirzepatide | 11 | $11,560 |
| JardianceEmpagliflozin | 18 | $10,557 |
| Gabapentin | 1,024 | $9,831 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBreztri Aerosphere, Farxiga, Bevespi Aerosphere | $1,214 | $166,534278 claims |
| AbbVieLinzess, Ubrelvy, Qulipta | $920 | $73,97089 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta, Shingrix | $184 | $51,159110 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $143 | $46,32528 claims |
| PfizerEliquis | $44 | $24,14945 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $37 | $1,48540 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.
Other family in Barbourville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.